3Kanis JA,Melton LJ 3rd,Christiansen C, etal,The diagnosis of osteoporosis [J].J Bone Miner Res,1994, 9:1137-1141.
4IOF hails WHO fracture Risk Assessment Report and FRAX website at milestones in osteoporosis prevention and treamentn[J].February,2008. Download as a POF.
2Physician's guide to prevention and treatment Of osteoporosis. Excerpt Medical, Inc. Bell Mead, 1999 New Jersey. National Osteoporosis Foundation.
3Lau E M. Epidemiology of "osteopomsis in urbanized Asia population Osteopomsis Int, 1997,7 (Suppl) : S91 - 95.
4Avioli LV. Epidemiology of osteopomsis and its complications. In:Peck WA, eds. Prevention of postmenopausal osteoporosis. Casterton Hall, Carnfirth, Lanes, LA6 2LA, UK. The Parthenon Publishing Group Ktd ,1990, 12 - 13.
5Lips P. Epidemiology and predictors of fractures associated with osteopomsis. Am J Med,103(2A) :3S - 11S.
6Melton LJ Ⅲ , Themer M, Ray NF, et al. Fracture attributable to osteoporosis: report from the National Osteoporosis Foundation.JBMR, 1997, 12 : 16 - 23.
7NOF. Clinician's guide to prevention and treatment of osteoporosis. http ://www. nof. org.
8Osteoporosls: Review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis introduction. Osteoporos Int, 1998, 8 (Suppl 4) :S7-S80.
9Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendrenate in women with osteoporesis: the fracture intervention trial. J Clin Endocrinol Metab, 2000, 85:4118-4124.
10Chesnut III CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporetic fractures study. Am J Med, 2000, 109:267-276.
